SLC4A2
Basic information
Region (hg38): 7:151057210-151076526
Previous symbols: [ "EPB3L1", "AE2" ]
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Osteopetrosis, autosomal recessive 9 | AR | Renal | An individual has been described with renal failure requiring renal transplant, and awareness may enable early diagnosis and management of renal issues and sequelae | Musculoskeletal; Renal | 34668226 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC4A2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 66 | 68 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 66 | 5 | 2 |
Variants in SLC4A2
This is a list of pathogenic ClinVar variants found in the SLC4A2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-151057808-T-C | Uncertain significance (Aug 10, 2022) | |||
7-151061996-C-G | not specified | Uncertain significance (May 28, 2024) | ||
7-151062021-G-A | not specified | Uncertain significance (Apr 19, 2023) | ||
7-151064203-C-T | Uncertain significance (-) | |||
7-151064211-G-A | Uncertain significance (-) | |||
7-151064244-G-A | Uncertain significance (-) | |||
7-151064312-C-T | Likely benign (Nov 01, 2022) | |||
7-151064325-G-C | not specified | Uncertain significance (May 12, 2024) | ||
7-151064545-C-T | Uncertain significance (-) | |||
7-151064589-G-A | not specified | Uncertain significance (Nov 15, 2023) | ||
7-151064594-C-T | not specified | Uncertain significance (Oct 26, 2021) | ||
7-151064610-G-T | not specified | Uncertain significance (Mar 01, 2023) | ||
7-151064628-G-A | Likely benign (Oct 01, 2023) | |||
7-151064693-G-T | not specified | Uncertain significance (Feb 06, 2024) | ||
7-151064720-C-T | not specified | Uncertain significance (May 30, 2024) | ||
7-151064771-C-T | Likely benign (Sep 01, 2023) | |||
7-151064878-C-T | not specified | Uncertain significance (Jun 11, 2021) | ||
7-151064879-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
7-151064891-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
7-151064918-T-C | not specified | Uncertain significance (Feb 27, 2024) | ||
7-151064944-G-A | Osteopetrosis, autosomal recessive 9 | Pathogenic (Oct 02, 2023) | ||
7-151066518-A-C | not specified | Uncertain significance (Mar 19, 2024) | ||
7-151066522-A-C | not specified | Likely benign (Nov 09, 2022) | ||
7-151066524-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
7-151066534-C-T | not specified | Likely benign (Jun 17, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC4A2 | protein_coding | protein_coding | ENST00000485713 | 22 | 19318 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.985 | 0.0148 | 125728 | 0 | 16 | 125744 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.97 | 566 | 803 | 0.705 | 0.0000541 | 7934 |
Missense in Polyphen | 193 | 362.16 | 0.53291 | 3624 | ||
Synonymous | 0.545 | 328 | 341 | 0.962 | 0.0000227 | 2683 |
Loss of Function | 5.56 | 9 | 52.5 | 0.172 | 0.00000299 | 550 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000151 | 0.000151 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000546 | 0.0000544 |
Finnish | 0.0000468 | 0.0000462 |
European (Non-Finnish) | 0.0000734 | 0.0000703 |
Middle Eastern | 0.0000546 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.000348 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Plasma membrane anion exchange protein of wide distribution.;
- Pathway
- Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);Salivary secretion - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Bicarbonate transporters
(Consensus)
Intolerance Scores
- loftool
- 0.0699
- rvis_EVS
- -1.77
- rvis_percentile_EVS
- 2.32
Haploinsufficiency Scores
- pHI
- 0.163
- hipred
- Y
- hipred_score
- 0.662
- ghis
- 0.595
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.454
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc4a2
- Phenotype
- growth/size/body region phenotype; endocrine/exocrine gland phenotype; craniofacial phenotype; cellular phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype; immune system phenotype;
Gene ontology
- Biological process
- anion transport;spermatogenesis;inorganic anion transport;bicarbonate transport;digestive tract development;regulation of intracellular pH;anion transmembrane transport
- Cellular component
- plasma membrane;integral component of plasma membrane;focal adhesion;membrane;basolateral plasma membrane;apical plasma membrane
- Molecular function
- inorganic anion exchanger activity;anion transmembrane transporter activity;anion:anion antiporter activity;enzyme binding